Protein Purification: Apollo 20 mL Ultrafiltration
Apollo ultrafiltration devices are used for purification, concentration or desalting of proteins and viral gene vector particles. They are available in 7 mL and 20 mL versions, each having 3 different membrane retention ratings: 9 kDa, 20 kDa, and 150 kDa.
APOLLO 20 mL CONCENTRATORS
Ultrafiltration using Apollo® Concentrators (US patents 6,269,957, 6,357,601) combines the highest recovery of regenerated cellulose membrane devices with faster concentration of protein samples and viral gene vectors than possible with recent high-speed devices of comparable retention.Apollo ultrafiltration devices are used for purification, concentration or desalting of proteins and viral gene vector particles. They are available in 7 mL and 20 mL versions, each having 3 different membrane retention ratings: 9 kDa, 20 kDa, and 150 kDa.
Orbital Biosciences
| Catalogue No. | Description | Pack Size | Price | Qty |
|
|---|---|---|---|---|---|
| AP-2000904 | 009 kDa APOLLO 20 mL CONCENTRATORS | 1 bag of 8 filters, tubes and caps | £70.00 | Quantity | Add to Order |
| AP-2000922 | 009 kDa APOLLO 20 mL CONCENTRATORS | 2 bags of 125 filters only | POA | Quantity | Add to Order |
| AP-2000942 | 009 kDa APOLLO 20 mL CONCENTRATORS | 1 bag of 100 filters only | £711.00 | Quantity | Add to Order |
| AP-2002004 | 020 kDaAPOLLO 20 mL CONCENTRATOR | 1 bag of 8 filters, tubes and caps | £70.00 | Quantity | Add to Order |
| AP-2002010 | 020 kDaAPOLLO 20 mL CONCENTRATOR | 1 rack of 25 filters, tubes and caps | £216.00 | Quantity | Add to Order |
| AP-2002022 | 020 kDaAPOLLO 20 mL CONCENTRATOR | 2 bags of 125 filters only | POA | Quantity | Add to Order |
| AP-2002042 | 020 kDaAPOLLO 20 mL CONCENTRATOR | 1 bag of 100 filters only | £711.00 | Quantity | Add to Order |
| AP-2015004 | 150 kDaAPOLLO 20 mL CONCENTRATOR | 1 bag of 8 filters, tubes and caps | £70.00 | Quantity | Add to Order |
| AP-2015010 | 150 kDaAPOLLO 20 mL CONCENTRATOR | 1 rack of 25 filters, tubes and caps | £216.00 | Quantity | Add to Order |
| AP-2015022 | 150 kDaAPOLLO 20 mL CONCENTRATOR | 2 bags of 125 filters only | POA | Quantity | Add to Order |
| AP-2015042 | 150 kDaAPOLLO 20 mL CONCENTRATOR | 1 bag of 100 filters only | £711.00 | Quantity | Add to Order |
Related products
APOLLO 20 mL CONCENTRATORS
Ultrafiltration using Apollo® Concentrators (US patents 6,269,957, 6,357,601) combines the highest recovery of regenerated cellulose membrane devices with faster concentration of protein samples and viral gene vectors than possible with recent high-speed devices of comparable retention.Apollo ultrafiltration devices are used for purification, concentration or desalting of proteins and viral gene vector particles. They are available in 7 mL and 20 mL versions, each having 3 different membrane retention ratings: 9 kDa, 20 kDa, and 150 kDa.
Orbital Biosciences
Apollo 20 mL High-Performance Concentrators
with Accelerated Conical Focusing
Use these centrifugal ultra filtration devices with combined simplicity, speed, capacity and recovery for quantitative concentration, purification and separation of proteins and viral gene vectors. Their unique truncated conical filtration chambers provide a high ratio of membrane area to sample size. This, in turn, provides a high degree of concentration in a single spin as well as better control of polarization and fouling at the membrane surface. Apollo has the largest available sample volumes for a given centrifuge tube size
- >90% quantitative recovery of micrograms of retained protein
- Quantative salt/buffer exchange in a single spin. 1000x plusconcentration factor capability
- Fast concentration of up to 20mL of protein or virus sample
- Biosafety No aerosol generation or air locking
- No need for hand contact with wet surfaces
- No invert spin required
click here for more details
Click here for a list of Apollo Citations
Available in packs of 8, 25,100 and 250.
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
APOLLO 20 mL CONCENTRATORS
Ultrafiltration using Apollo® Concentrators (US patents 6,269,957, 6,357,601) combines the highest recovery of regenerated cellulose membrane devices with faster concentration of protein samples and viral gene vectors than possible with recent high-speed devices of comparable retention.Apollo ultrafiltration devices are used for purification, concentration or desalting of proteins and viral gene vector particles. They are available in 7 mL and 20 mL versions, each having 3 different membrane retention ratings: 9 kDa, 20 kDa, and 150 kDa.
Orbital Biosciences
Click here to download protocol
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
APOLLO 20 mL CONCENTRATORS
Ultrafiltration using Apollo® Concentrators (US patents 6,269,957, 6,357,601) combines the highest recovery of regenerated cellulose membrane devices with faster concentration of protein samples and viral gene vectors than possible with recent high-speed devices of comparable retention.Apollo ultrafiltration devices are used for purification, concentration or desalting of proteins and viral gene vector particles. They are available in 7 mL and 20 mL versions, each having 3 different membrane retention ratings: 9 kDa, 20 kDa, and 150 kDa.
Orbital Biosciences
Examples of recent publications citing the use of Orbital Biosciences" Apollo concentrators:
Boss IW, Nadeau PE, Abbott JR, Yang Y, Mergia A, Renne R. A Kaposi"s sarcoma-associated herpesvirus-encoded ortholog of microRNA miR-155 induces human splenic B-cell expansion in NOD/LtSz-scid IL2Rγnull mice. J Virol. 2011 85:9877-86.
DiMattia MA, Nam HJ, Van Vliet K, Mitchell M, Bennett A, Gurda BL, McKenna R, Olson NH, Sinkovits RS, Potter M, Byrne BJ, Aslanidi G, Zolotukhin S, Muzyczka N, Baker TS, Agbandje-McKenna M. Structural insight into the unique properties of adeno-associated virus serotype 9. J Virol. 2012 86:6947-58.
Doerfler PA, Byrne BJ, Clément N. Copackaging of multiple adeno-associated viral vectors in a single production step. Hum Gene Ther Methods. 2014 25:269-76.
Halder S, Van Vliet K, Smith JK, Duong TT, McKenna R, Wilson JM, Agbandje-McKenna M. Structure of neurotropic adeno-associated virus AAVrh.8. J Struct Biol. 2015 192:21-36.
Higuchi M, Haginoya K, Yamazaki T, Miyamoto K, Katagiri T, Tomimoto K, Shitomi Y, Hayakawa T, Sato R, Hori H. Binding of Bacillus thuringiensis Cry1A toxins to brush border membrane vesicles of midgut from Cry1Ac susceptible and resistant Plutella xylostella. Comparative Biochemistry and Physiology Part B: Biochemistry and Molecular Biology 2007 147: 716–724.
Hori Y, Hashimoto T, Nomoto H, Hyman BT, Iwatsubo T. Role of Apolipoprotein E in β-Amyloidogenesis: Isoform-Specific Effects on Protofibril to Fibril Conversion of Aβ in vitro and Brain Aβ Deposition in vivo. J Biol Chem. 2015 290:15163-7.
Kuboshima M, Shimada H, Liu TL, Nomura F, Takiguchi M, Hiwasa T, Ochiai T. Presence of serum tripartite motif-containing 21 antibodies in patients with esophageal squamous cell carcinoma. Cancer Science 2006 97:380-386.
Mahajan MC, Narlikar GJ, Boyapaty G, Kingston RE, Weissman SM. Heterogeneous nuclear ribonucleoprotein C1/C2, MeCP1, and SWI/SNF form a chromatin remodeling complex at the beta-globin locus control region. Proc Natl Acad Sci U S A. 2005 102:15012-7.
Méndez-Gómez, H. R., Galera-Prat, A., Meyers, C., Chen, W., Singh, J., Carrión-Vázquez, M., & Muzyczka, N. Transcytosis in the blood–cerebrospinal fluid barrier of the mouse brain with an engineered receptor/ligand system. Molecular Therapy. Methods & Clinical Development 2015 2, 15037.
Okai M, Kudo N, Lee WC, Kamo M, Nagata K, Tanokura M. Crystal structures of the short-chain flavin reductase HpaC from Sulfolobus tokodaii strain 7 in its three states: NAD(P)( )(-) free, NAD( )(-) bound, and NADP( )(-) bound. Biochemistry. 2006 45:5103-10.
Pandya J, Ortiz L, Ling C, Rivers A & Aslanidi G. Rationally designed capsid and transgene cassette of AAV6 vectors for dendritic cell-based cancer immunotherapy. Immunology and Cell Biology 2014 92, 116–123.
Reddy VB, Iuga AO, Kounga K, Lerner EA. Functional analysis of recombinant mutants of maxadilan with a PAC1 receptor-expressing melanophore cell line. J Biol Chem. 2006 281:16197-201.
Reisz JA, Zink CN, King SB. Rapid and selective nitroxyl (HNO) trapping by phosphines: kinetics and new aqueous ligations for HNO detection and quantitation. J Am Chem Soc. 2011 133:11675-85.
Sayroo R, Nolasco D, Yin Z, Colon-Cortes Y, Pandya M, Ling C, Aslanidi G. Development of novel AAV serotype 6 based vectors with selective tropism for human cancer cells. Gene Ther. 2016 23:18-25.
Tsunetsugu-Yokota Y, Ato M, Takahashi Y, Hashimoto S, Kaji T , Kuraoka M, Yamamoto K, Mitsuki Y, Yamamoto T, Oshima M, Ohnishi K & Takemori T. Formalin-Treated UV-Inactivated SARS Coronavirus Vaccine Retains Its Immunogenicity and Promotes Th2-Type Immune Responses. Jpn. J. Infect. Dis. 2007 60: 106-112.
If you cannot find the answer to your problem below then please contact us or telephone 01954 210 200
AthensResearch&Technology公司位于美国乔治亚州雅典市，从1986年以来一直致力于纯化高纯度，高活性的人类蛋白质和开发这些蛋白的多克隆抗血清。我们的常规产品包括丝氨酸蛋白酶、蛋白酶抑制剂、中性粒细胞酶、载脂蛋白、脂蛋白，血小板蛋白、转铁蛋白、免疫球蛋白等。二十年多年来，世界各地的研究人员都在使用我们公司的产品。在炎症、冠状动脉疾病、自身免疫性疾病、癌症、老年痴呆症等等研究的主要科学出版物中都能看到引用我们公司的产品。我们提供优质，可靠的产品和出色的客户服务。我们期待着您的业务。如果需要定制研究服务，AthensResearch&Technology公司能够根据您的项目要求提供无与伦比的试剂。
公司主要产品：一、凝血因子相关系列产品：包括多款从人血浆、血小板中分离纯化的凝血因子相关蛋白。二、酶及抑制剂系列产品：包括多款从人血浆、红细胞分离纯化的a-抗糜蛋白酶、a1/2抗胰蛋白酶、抗凝血酶、C1酯酶抑制因子、Calpain-1等酶及其抑制剂产品。三、免疫球蛋白系列产品：包括多款从人血浆、骨髓瘤、初乳以及狗和小鼠血浆中分离纯化的免疫球蛋白产品。四、脂蛋白及载脂蛋白系列产品：包括包括多款从人血浆中分离纯化的载脂蛋白及脂蛋白（高密度、中等密度、低密度、极低密度脂蛋白）产品。五、低内毒素蛋白系列产品：包括多款适宜于细胞培养的低内毒素脂蛋白、免疫球蛋白及转铁蛋白产品。六、乳蛋白系列产品：包括从人乳中分离纯化的乳白蛋白、乳铁传递蛋白及分泌型免疫球蛋白A。七、中性粒细胞源蛋白系列产品：包括多款纯化分离自人中性粒细胞的Azurocidin 、CathepsinG及Lactoferrin等蛋白产品。八、血小板相关系列产品：包括纯化分离自人血小板的血小板因子4及凝血酶致敏蛋白。九、转铁蛋白及脱铁转铁蛋白（APOTRANSFERRINS）系列产品：包括多款纯化分离自人、大小鼠、狗及食蟹猴血浆中的转铁蛋白/脱铁转铁蛋白，可应用于细胞或组织培养。十、抗体系列产品：包括多款兔、大鼠、羊源的多克隆抗体产品。
ebiomall.com
